Brief: Egetis And Er-Kim Expand Partnership
Dec 10 (Reuters) - Egetis Therapeutics AB (publ) EGTX.ST: EGETIS AND ER-KIM EXPAND PARTNERSHIP TO BROADEN ACCESS TO EMCITATE® ACROSS CENTRAL, EASTERN, AND SOUTHEASTERN EUROPE EMCITATE DISTRIBUTION EXPANDED TO 15 EUROPEAN COUNTRIES INITIAL AGREEMENT SIGNED IN JUNE 2025 COVERING TÜRKİYE Source text: ID:nMFN4C8XkZ Further company coverage: EGTX.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Egetis Therapeutics AB (publ)
See all newsBrief: Egetis Announces Grant Of Patent For MCT8 Deficiency Composition In U.S.
Swedisg drugmaker Egetis's Q1 revenue rises 9% on Emcitate sales in Europe
Brief: Egetis Therapeutics Q1 Loss SEK 94.5 Mln
Brief: Egetis Plans Directed Share Issue Raising SEK 350 Million
Brief: Egetis Therapeutics Appoints Tiago Nunes As CMO Effective May 1